MondayAug 07, 2017 9:31 am

HempNewsBreaks – ChineseInvestors.com, Inc. (CIIX) Names Keevin Gillespie as Acting President of ChineseHempOil.com Subsidiary

Market analysis company ChineseInvestors.com, Inc. (OTCQB: CIIX) this morning announced that it has appointed Keevin Gillespie as acting president of its wholly-owned ChineseHempOil.com, Inc. subsidiary, effective immediately. Per the update, Gillespie’s initial focus will be on promotion and branding of the company’s newly-launched ‘OptHemp’ health product line, which the company intends to market through several sales channels. He will also be spearheading the development of the company’s network marketing division. “I'm honored to serve as the President of ChineseHempOil.com, Inc.,” Gillespie stated in the news release. “As the many potential health benefits of hemp continue to be revealed through scientific…

Continue Reading

MondayAug 07, 2017 9:05 am

HempNewsBreaks – SinglePoint, Inc. (SING) Provides First-Hand Look at Development of New Bitcoin Exchange

Specialized holding company SinglePoint, Inc. (OTC: SING) this morning offered a first-hand look at its new bitcoin exchange aimed at solving the payments issues plaguing today’s cannabis industry. When completed, the new in-house solution will enable consumers to obtain bitcoin at any point of sale. In addition to bitcoin, SinglePoint is currently in negotiations to make a major purchase from a company that offers a cannabis-specific cryptocurrency to be used specifically within the growing legal cannabis industry, which is on pace to reach $55.8 billion by 2025, per Grand View Research. “We are very excited about this solution,” Wil Ralston,…

Continue Reading

ThursdayAug 03, 2017 12:12 pm

HempNewsBreaks – SeeThruEquity Updates Coverage on Earth Science Tech, Inc. (ETST)

SeeThruEquity has updated its coverage and issued a price target of $4.12 on shares of Earth Science Tech, Inc.’s (OTC: ETST) stock. Among other highlights, the analyst noted the company’s new joint venture with Varsity Group, LLC to use its patented Kanna-Blend formula to develop CBD-based e-liquids to be sold under ETST's subsidiary, KannaBidoid Inc. The company has already finalized four product labels for it e-liquids that will start selling by the end of August 2017. Additionally, ETST has inked an agreement with Absolu Communications to handle the branding and rollout of the company’s much-anticipated MSN-2 medical device. For more…

Continue Reading

ThursdayAug 03, 2017 12:08 pm

HempNewsBreaks – CHF Solutions, Inc. (NASDAQ: CHFS) Starts Aquadex FlexFlow® System Manufacturing Transition to its Minnesota Facility; Shares Rise

CHF Solutions, Inc. (NASDAQ: CHFS) shares surged 14% after the company this morning said it has commenced the process of transitioning the manufacturing of the Aquadex FlexFlow System from an indirect subsidiary of Baxter International, Inc. (NYSE: BAX) to CHF Solutions’ facility in Eden Prairie, Minnesota. Last week, the company completed the transfer of the manufacturing assets that it acquired from Baxter as part of the Aquadex acquisition that was completed on August 5, 2016. The company expects to begin manufacturing its Aquadex FlexFlow system products in the fourth quarter of 2017. “Bringing the manufacturing of the Aquadex FlexFlow system…

Continue Reading

ThursdayAug 03, 2017 12:05 pm

HempNewsBreaks – Moleculin Biotech, Inc. (NASDAQ: MBRX) Selects Bioscience SA as Polish CRO

Shares of Moleculin Biotech (NASDAQ: MBRX) rose 7% this morning on news that the company has selected Bioscience SA, a Polish contract research organization (CRO), to begin identifying and preparing clinical testing sites in Poland for Annamycin. The company’s drug candidate, Annamycin, is being evaluated for the treatment of relapsed or refractory acute myeloid leukemia (AML). "One of the biggest challenges for most clinical trials is recruiting the right patients on a timely basis. We believe adding Polish sites to our planned trial introduces a significant population of qualified patients, and selecting Bioscience helps ensure we reach those patients effectively…

Continue Reading

ThursdayAug 03, 2017 12:00 pm

HempNewsBreaks – Micronet Enertec Technologies, Inc. (NASDAQ: MICT) Receives Largest Purchase Order Since 2012; Shares Higher

Micronet Enertec Technologies (NASDAQ: MICT) shares surged 34% this morning after the company said its Mobile Resource Management (MRM) subsidiary Micronet Ltd., via its wholly owned subsidiary Micronet Inc., has received purchase orders valued at approximately $4.3 million for its recently released TREQr5 product. The orders for the ruggedized telematics Android on-board computer were received by a fleet management solutions provider that is a current customer. The purchase order marks the largest order received for the company since 2012 and brings the company’s backlog to a record amount of $13.5 million. "The magnitude of these orders, and the fact that…

Continue Reading

ThursdayAug 03, 2017 9:08 am

HempNewsBreaks – India Globalization Capital, Inc. (NYSE: IGC) Management Quoted in “HIGH TIMES” Article

India Globalization Capital, Inc. (NYSE MKT: IGC), a developer of cannabis-based therapies to treat a variety of life-altering conditions, this morning announced the publication of “Marijuana Could Help Treat Alzheimer’s: Here’s How It Would Work” on August 1, 2017, by Javier Hasse on the website of “HIGH TIMES,” a publication that’s served as the preeminent source for cannabis information since 1974. In the article, both Ram Mukunda, CEO of IGC, and Dr. Chuanhai Cao, the company’s key advisor, were quoted with respect to the potential therapeutic effects of THC on Alzheimer’s disease, which is noted as America’s most expensive ailment.…

Continue Reading

WednesdayAug 02, 2017 3:23 pm

HempNewsBreaks – Lexaria Bioscience Corp. (CSE: LXX) (OTCQB: LXRP) Spotlighted by Technical420

Lexaria Bioscience Corp. (CSE: LXX) (OTCQB: LXRP), a company engaged in licensing proprietary technology for the delivery of bioactive compounds, including cannabinoids, was recently spotlighted in an article on Technical420.com. The publication highlighted, in detail, several of the company’s key developments and growth catalysts. “During the last few months, Lexaria has improved its fundamental story through the following developments: 1) The company applied for a new patent from the U.S., 2) Lexaria has advanced its agreements and launched new businesses, 3) Expands its Reach into Asia, 4) Focused on R&D with major organizations, and 5) The company’s cash position has…

Continue Reading

WednesdayAug 02, 2017 11:22 am

HempNewsBreaks – ReWalk Robotics (NASDAQ: RWLK) Shares Higher on Publication of Restore™ System Enhancing Walking Ability for Stroke Survivors

Shares of ReWalk Robotics (NASDAQ: RWLK) are up 15% this morning after the company’s Restore™ System was utilized in a study published in the Journal of Science Translational Medicine. The study found that use of a soft suit exoskeleton system enabled normal walking ability for ambulatory patients following a stroke. The prototype utilized in the study was created by the Wyss Institute and is now moving toward commercialization by ReWalk Robotics. "The ongoing research at the Wyss Institute on soft exosuits adds a new dimension to exoskeletons that can potentially meet the needs of individuals that have had a stroke,…

Continue Reading

WednesdayAug 02, 2017 11:18 am

HempNewsBreaks – Celsion Corporation (NASDAQ: CLSN) Trading Higher following Positive Translational Data from OVATION Study

Celsion (NASDAQ: CLSN) this morning reported “convincing evidence” of gene transfer and immune system activity from its OVATION Study combining the company’s GEN-1 gene-mediated immunotherapy with the standard of care for newly diagnosed patients with advanced ovarian cancer. “These translational research findings demonstrate that GEN-1 in ovarian cancer patients is biologically active and creates a shift in the tumor microenvironment in the peritoneal cavity in a dose-dependent manner and promotes a pro-immune T-cell population dynamic in the tumor microenvironment,” Dr. Khursheed Anwer, Celsion’s executive vice president and chief science officer, stated in the press release. “These distinct immunological changes in…

Continue Reading

HempWire Currently Accepts

Bitcoin

Bitcoin

Bitcoin Cash

Bitcoin Cash

Doge Coin

Dogecoin

Ethereum

Ethereum

Litecoin

Litecoin

USD Coin

USD Coin

Contact us: 303.498.7722